See more : Grupo Traxión, S.A.B. de C.V. (TRAXIONA.MX) Income Statement Analysis – Financial Results
Complete financial analysis of Solasto Corporation (6197.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Solasto Corporation, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Mithra Pharmaceuticals SA (MITRA.BR) Income Statement Analysis – Financial Results
- Intel Corporation (INL.DE) Income Statement Analysis – Financial Results
- Vadilal Industries Limited (VADILALIND.BO) Income Statement Analysis – Financial Results
- Stora Enso Oyj (STE-R.ST) Income Statement Analysis – Financial Results
- Clean Life Co. (9581.SR) Income Statement Analysis – Financial Results
Solasto Corporation (6197.T)
About Solasto Corporation
Solasto Corporation provides medical outsourcing services primarily to medical institutions in Japan. The company's medical outsourcing services include contracted services of medical clerical work. It also offers elderly care services, such as day service, home help, facility-based service, etc.; and childcare services, as well as engages in the education business. The company was formerly known as N.I.C Corporation. Solasto Corporation was founded in 1965 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 135.14B | 131.09B | 117.24B | 106.18B | 95.72B | 84.25B | 74.33B | 65.41B | 63.07B | 60.18B | 58.42B |
| Cost of Revenue | 113.21B | 109.34B | 96.78B | 87.32B | 78.72B | 69.09B | 61.35B | 54.25B | 52.47B | 50.54B | 48.59B |
| Gross Profit | 21.93B | 21.75B | 20.46B | 18.86B | 17.00B | 15.16B | 12.98B | 11.17B | 10.60B | 9.64B | 9.84B |
| Gross Profit Ratio | 16.23% | 16.59% | 17.45% | 17.76% | 17.76% | 17.99% | 17.47% | 17.07% | 16.81% | 16.01% | 16.84% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 14.59B | 13.69B | 12.74B | 11.51B | 11.54B | 10.13B | 8.79B | 7.51B | 7.29B | 7.02B | 7.26B |
| Other Expenses | 1.82B | 188.00M | 64.00M | 122.00M | 14.00M | 37.00M | -5.95M | -8.79M | 31.44M | 0.00 | 0.00 |
| Operating Expenses | 16.42B | 15.43B | 14.14B | 12.80B | 11.54B | 10.13B | 8.79B | 7.51B | 7.29B | 6.96B | 6.21B |
| Cost & Expenses | 129.62B | 124.76B | 110.92B | 100.12B | 90.25B | 79.22B | 70.14B | 61.76B | 59.76B | 57.50B | 54.80B |
| Interest Income | 0.00 | 272.00M | 188.00M | 16.00M | 17.00M | 99.00M | 84.00K | 37.00K | 2.67M | 52.00M | 67.00M |
| Interest Expense | 288.00M | 272.00M | 237.00M | 215.00M | 160.00M | 99.00M | 61.59M | 46.01M | 58.72M | 0.00 | 0.00 |
| Depreciation & Amortization | 3.34B | 3.14B | 2.60B | 2.34B | 1.95B | 1.51B | 1.01B | 579.21M | 606.97M | -2.62B | -2.58B |
| EBITDA | 7.77B | 9.46B | 8.92B | 8.40B | 7.42B | 6.54B | 5.19B | 4.27B | 3.84B | 64.96M | 1.05B |
| EBITDA Ratio | 5.75% | 7.36% | 7.66% | 8.04% | 7.78% | 7.81% | 6.98% | 6.46% | 6.27% | 0.01% | 1.67% |
| Operating Income | 5.52B | 6.33B | 6.32B | 6.06B | 5.47B | 5.03B | 4.19B | 3.65B | 3.31B | 2.62B | 2.58B |
| Operating Income Ratio | 4.08% | 4.83% | 5.39% | 5.71% | 5.71% | 5.97% | 5.64% | 5.59% | 5.25% | 4.36% | 4.42% |
| Total Other Income/Expenses | -1.38B | -907.00M | -678.00M | -708.00M | 1.50B | -76.00M | -88.00M | -14.97M | -139.82M | 8.00M | 977.00M |
| Income Before Tax | 4.14B | 5.42B | 5.64B | 5.35B | 6.97B | 4.95B | 4.10B | 3.64B | 3.17B | 2.63B | 3.56B |
| Income Before Tax Ratio | 3.06% | 4.13% | 4.81% | 5.04% | 7.28% | 5.88% | 5.52% | 5.56% | 5.03% | 4.37% | 6.09% |
| Income Tax Expense | 1.88B | 2.25B | 2.14B | 1.82B | 2.23B | 1.45B | 1.39B | 1.17B | 1.18B | 1.18B | 1.17B |
| Net Income | 2.26B | 3.17B | 3.50B | 3.54B | 4.74B | 3.51B | 2.71B | 2.47B | 1.99B | 1.45B | 2.39B |
| Net Income Ratio | 1.67% | 2.42% | 2.99% | 3.33% | 4.95% | 4.16% | 3.65% | 3.78% | 3.16% | 2.41% | 4.10% |
| EPS | 24.10 | 33.53 | 37.08 | 37.51 | 50.33 | 37.49 | 28.75 | 28.51 | 23.50 | 17.11 | 28.23 |
| EPS Diluted | 24.10 | 33.53 | 37.02 | 37.41 | 50.12 | 37.10 | 28.75 | 26.38 | 23.50 | 17.11 | 28.23 |
| Weighted Avg Shares Out | 93.66M | 94.63M | 94.47M | 94.34M | 94.17M | 93.51M | 91.79M | 86.74M | 84.81M | 84.82M | 84.81M |
| Weighted Avg Shares Out (Dil) | 93.66M | 94.63M | 94.60M | 94.57M | 94.55M | 94.50M | 94.26M | 93.74M | 84.81M | 84.82M | 84.81M |
Source: https://incomestatements.info
Category: Stock Reports